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Abstract The human N-acetylglucosaminyltransferase I gene
was introduced in the genome of Trichoderma reesei strain VTT-
D-80133. Expression was studied after induction from the
cellobiohydrolase I promoter. Successful in vivo transfer of
GlcNAc was demonstrated by analyzing the neutral N-glycans
which were synthesized on cellobiohydrolase I. Final proof of the
formation of GlcNAcMan5GlcNAc2 was obtained by NMR
analysis.
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1. Introduction
Filamentous fungi are known as saprophytic organisms
which secrete high amounts of sugar polymer, degrading en-
zymes in order to obtain the necessary carbon sources for
their growth. Because of their high secretion capacity, they
are attractive potential host organisms for the production of
glycoproteins with therapeutic importance. At present, several
attempts have been made to obtain high amounts of heterol-
ogous proteins in fungal species such as Aspergillus, Tricho-
derma and Neurospora [1^3]. The presence, however, of high-
mannose type glycans hampers their real application. An anti-
genic response is often elicited for which certain substituents
such as terminal galactoses or K-1,3-mannoses are held re-
sponsible [4]. In addition, terminal mannose residues are rec-
ognized by lectins present in the mammalian body. Conse-
quently, the recombinant glycoproteins are rapidly cleared
from the blood [5]. To prevent such clearing, the N-glycans
should have terminal sialic acid residues. Several methods can
be designed and tested to obtain fungally produced proteins
that can be sialylated easily. As reported before, it is possible
to convert at least a fraction of the fungal N-glycans to the
mammalian type by in vitro mimicking of the mammalian
synthesis pathway [6]. The next step in this e¡ort is to intro-
duce the genes of mammalian glycosyltransferases in the ge-
nome of ¢lamentous fungi to express them intracellularly so
that the number of necessary in vitro steps remains limited.
The key enzyme to the complex oligosaccharide synthesis is
N-acetylglucosaminyltransferase I (GlcNAc-TI: EC 2.4.1.101),
which incorporates N-acetylglucosamine residues to K-1,3-
linked mannose of the core oligosaccharide Man5GlcNAc2.
Introduction of the rabbit GlcNAc-TI gene in the genome
of Aspergillus nidulans has already been demonstrated [7].
GlcNAc-TI activity was detected intracellularly, but there
was no evidence of in vivo transfer of GlcNAc residues to
fungal glycans, nor was it possible to precisely de¢ne the
subcellular location of the enzyme. Here, we studied the in
vivo expression of human GlcNAc-TI in the ¢lamentous fun-
gus Trichoderma reesei.
2. Materials and methods
2.1. Strain, media and growth conditions
T. reesei strain VTT-D-80133 [8] was obtained from Primalco (Hel-
sinki, Finland) and served as expression host. A minimal non-selective
growth medium was used [9]. Glucose was added as a carbon source
to the medium to maximize the biomass. The fungal cells were grown
in 6 l medium for 7 days at 28‡C and at 250 rpm. The cells were
collected after centrifugation and transferred to lactose containing
medium to induce the simultaneous expression of cellobiohydrolase
I (CBHI) and GlcNAc-TI. After 7 days of induction, the cells were
separated from the extracellular medium by centrifugation and ¢ltra-
tion.
2.2. Construction of a GlcNAc-TI expression vector
The encoding region of the human GlcNAc-TI gene was ampli¢ed
and cloned into a pUC18 vector [6]. To facilitate further cloning
work, the GlcNAc-TI gene was subcloned between the BamHI and
HindIII sites of pGEM11Zf(+) (Promega Biotec, Madison, WI, USA).
The T. reesei expression vector pEN208 [10] was ¢rst modi¢ed for
cloning of the GlcNAc-TI gene. To that end, 5P-TCGGCC-3P was
changed by site-speci¢c mutagenesis at the end of the CBHI signal
sequence to 5P-TCGCGA-3P, the latter being an NruI site. The plas-
mid was then cut by NruI and BclI and the BclI site was blunted using
T4 polymerase. Self-ligation was prevented by dephosphorylation us-
ing calf intestine alkaline phosphatase. The GlcNAc-TI gene was
recovered from pGEM11Zf(+) after HindII digestion and ligated
into pEN208. The nucleotide sequence 5P-TCGGACCTCGAGG-
GATCCTCTAGAGTCTCCAGGATG-3P consists of a NruI/HindII
ligation site up to the GlcNAc-TI start codon, as well as of a BamHI
restriction site (italicized). To remove the CBHI signal sequence, a
partial MstI digestion was performed. With another preparation of
the same plasmid, the BamHI site close to the start codon was cut and
then blunted by T4 polymerase. After NsiI digestion, the GlcNAc-TI
gene was recovered and then ligated in blunted MstI- and NsiI-di-
gested pEN208 to result in pENhGNTI1.
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2.3. Transformation of T. reesei VTT-D-80133
Transformation of the fungal cells was obtained after protoplasting
of the cells [9]. p3SR2 was co-transformed in order to allow selection
of transformants that were able to grow on minimal medium with
acetamide as the only nitrogen source [10]. Transformants were col-
lected after 7 days of growth. They were submitted to a second and a
third round of selection by transferring the mycelium to fresh minimal
medium plates containing acetamide as the only nitrogen source. Fi-
nally, transformants were sporulated on potato dextrose agar plates,
after which spores were resuspended in 0.9% NaCl/20% glycerol to
allow storage at 370‡C.
2.4. Southern blot analysis
Spores were inoculated in minimal medium [9], to which 0.05%
yeast extract, 0.05% peptone and 0.02% corn steep liquor were added.
Cells were grown at 30‡C for 7 days. Mycelium was precipitated by
centrifugation and resuspended into lactose containing minimal me-
dium. After 2 days, cells were collected by centrifugation and pressed
between ¢lter paper to remove extracellular liquid as much as possi-
ble. Genomic DNA was prepared as described [11]. One sample of
DNA (approximately 10 Wg) was double-digested with Eco47III/NsiI,
while another sample was double-digested with XbaI/NsiI (reference
DNA was from phage lambda digested with PstI). The digests were
submitted to gel electrophoresis over a 1% agarose gel. After staining
with ethidium bromide to check the quality of the digested DNA,
Southern blotting was performed using standard protocols [12]. A
probe was prepared by random prime labelling of 100 ng of a
GlcNAc-TI gene fragment which was isolated from a mammalian
expression plasmid pCAMFhGNTIf1 [6]. The speci¢c activity of the
obtained probe was 3.2U104 dpm/ng. As a reference, PstI-digested
lambda DNA was labelled by random priming and hybridized to its
own DNA. The blot was exposed to a Phosphorimager screen
(Molecular Dynamics, Sunnyvale, CA, USA) to detect radioactive
signals.
2.5. Lectin screening
Spores (2U109) of transformants were inoculated in 200 ml lactose
containing minimal medium and grown at 30‡C for 8 days. The ex-
tracellular medium was collected after precipitating the T. reesei cells
by centrifugation and ¢ltration. The medium was 30-fold concen-
trated by ultra¢ltration using Microcon-10 devices (Amicon, Danvers,
MA, USA). 15 Wl was loaded in the wells of a 12.5% polyacrylamide
gel to electrophoretically separate denatured proteins. The extracellu-
lar proteins were then blotted according to standard procedures. The
blot was screened using Bandeiraea simplicifolia agglutinin II, which
binds speci¢cally to terminal GlcNAc residues [13].
2.6. Production and puri¢cation of CBHI
Spores were inoculated and grown in 4 l glucose containing growth
medium for 7 days, after which the mycelium was changed to induc-
tion medium. After 7 days, the extracellular medium was collected
and mycelium was resuspended in 2 l induction medium to allow extra
production of CBHI. Puri¢cation of CBHI was achieved as described
[14,15], the only di¡erence being a repetition of the anion exchange
puri¢cation step to replace ¢nal puri¢cation over an a⁄nity column.
The protein concentration was determined according to Bradford and
using BSA as standard protein.
2.7. Isolation and fractionation of N-glycans
Approximately 250 mg of CBHI was deglycosylated by PNGase F.
CBHI was denatured by boiling for 5 min in 50 mM Tris-Cl pH 8.0,
0.5% SDS and 1% L-mercaptoethanol. After addition of NP-40 to 1%
¢nal concentration, 100 000 U of PNGase F was added. After 24 h
incubation at 37‡C, 50 000 extra U was added and incubated for
another 24 h. Released N-glycans were collected by acetone precip-
itation and resuspension into 60% methanol [16]. By repeating acetone
precipitation, most detergent was removed. The mixture of N-glycans
was loaded and fractionated over a Biogel P4 column (Bio-Rad, Rich-
mond, CA, USA) [17].
2.8. Analysis of CBHI N-glycans by £uorophore-assisted carbohydrate
electrophoresis (FACE)
A small fraction of the N-glycan mixture and samples of the frac-
tionated oligosaccharides were £uorescently labelled with 8-amino-
1,3,6-naphthalene trisulfonic acid (ANTS) or aminoacridone and sub-
mitted to FACE analysis [18]. Electro£uorograms were recorded with
a LumiImager F1 (Boehringer Mannheim, Mannheim, Germany).
Commercial high-mannose N-glycans from bovine pancreas ribonu-
clease B (Oxford Glycosystems, Reading, UK) served as references. In
addition, an oligo-glucose ladder was prepared by hydrolyzing dex-
trane [17].
2.9. NMR analysis
Approximately 250 Wg of oligosaccharides was dissolved in 0.7 ml
deuterium oxide (Aldrich Chemical, Milwaukee, WI, USA), without
internal reference. The 1H-NMR spectrum was measured on a
UNITY-500 spectrometer, operating at 499.478 MHz (Varian Ana-
lytical Instruments, San Fernando, CA, USA). The experiment was
performed with a 5 mm inverse detection probe equipped with pulsed
magnetic ¢eld gradient coils. The standard Varian software vnmr
version 6.1 was used throughout. The spectrum was run at 27‡C
and referenced to the value of the high-¢eld methyl proton line of
sodium acetate (N 1.91) by applying the value of the high-¢eld methyl
proton line of the GlcNAc acetates (N 2.03). The 1H-90‡ pulses were
5.5 Ws. Presaturation was chosen in order to suppress the water peak,
with a pulse of 2 ms and a power of 2 dB. An exponential weighting
function lb = 0.75 was used.
3. Results
3.1. Transformation of GlcNAc-TI
In order to express human GlcNAc-TI in T. reesei, the
corresponding gene was ampli¢ed and cloned in pEN208.
After random integration in the genome of this ¢lamentous
fungus, the CBHI promoter was induced after depletion of
glucose in the growth medium and by adding an inducing
carbon source such as lactose. Several acetamidase-positive
transformants were obtained. Successful integration of
pENhGNTI1 was analyzed by Southern blotting. After hy-
bridization with a GlcNAc-TI gene fragment to Eco47III/
NsiI and with XbaI/NsiI-digested genomic DNA of the trans-
formants, expected bands of 1230 bp and 1350 bp, respec-
tivily, were detected (result not shown). Southern blotting
con¢rmed the presence of at least one intact expression
cassette for GlcNAc-TI.
3.2. Lectin screening
After blotting extracellular proteins to a nitrocellulose
membrane, screening with B. simplicifolia II lectin resulted
in detection of transformants which apparently synthesized
Fig. 1. Lectin screening. Comparable amounts of extracellular pro-
teins from di¡erent transformants were submitted to PAGE, blotted
and screened with a GlcNAc-speci¢c lectin of B. simplicifolia. Pro-
teins from non-transformed T. reesei strain VTT-D-80133 were
screened (lane 1). Lanes 2^9 contain secreted glycoproteins from dif-
ferent transformants. The transformant T6 produced CBHI which
bound lectin better (lane 5) than CBHI of most other transform-
ants. M, low molecular mass marker proteins.
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extra terminal GlcNAc residues (Fig. 1). Enhanced binding to
some proteins (presumably EGI and/or CBHII and some oth-
er unidenti¢ed proteins) of the transformants was observed.
One transformant, designated as T6, produced CBHI which
bound lectin better than CBHI of most other transformants
and was therefore chosen for large scale production and pu-
ri¢cation of CBHI to allow a detailed analysis of N-glycans.
3.3. Analysis of N-glycans by FACE
ANTS-labelled glycan mixtures from CBHI from the non-
transformed VTT-D-80133 strain and from transformant T6
were submitted to electrophoresis. A slower migration behav-
ior was observed with N-glycans from the transformed strain
(Fig. 2). A fraction of the oligosaccharides of the transformed
strain migrated to a position between Glc6 and Glc7 of the
oligoglucose standard ladder, which is the expected position
of GlcNAcMan5GlcNAc2. A fraction of the N-glycans from
the non-transformed strain, which migrated to the position of
Glc5, was not detected anymore in the N-glycan pattern of the
transformant T6. This is in accordance with an expected up-
ward shift corresponding to addition of one extra sugar
monomer. The fact that more than one compound shifted
was interpreted as a possibility that GlcNAc-TI used other
acceptors besides the expected Man5GlcNAc2.
3.4. Fractionation and puri¢cation of CBHI N-glycans
To prepare glycans for NMR analysis, fractionation and
puri¢cation by gel ¢ltration were performed. As previously
observed with N-glycans from T. reesei strain RUTC 30
[15], only two pure compounds were obtained, their elution
positions corresponding to those expected for Man5GlcNAc2
and GlcNAcMan5GlcNAc2. The other glycans eluted at or
close after the void and were only partially fractionated, ren-
dering their characterization by NMR impossible.
3.5. Mass spectrometry
Spectrograms of puri¢ed and fractionated N-glycans
showed that the molecular mass of the compounds analyzed
was 1235 Da and 1438 Da, which corresponds to the molec-
ular mass of Man5GlcNAc2 and GlcNAcMan5GlcNAc2, re-
spectively.
3.6. 1H-NMR data of compound 1 identi¢ed as Man5GlcNAc2
The anomeric region of the 1H-NMR spectrum (N 4.4^5.4)
of compound 1 shows six resonances (besides an impurity at
N 4.816). There is a doublet at N 5.184 (integrating for 0.4
protons), two collapsing singlets at N 5.094 (integrating for
two protons), three enlarged singlets at N 4.776, N 4.868 and
N 4.904, each integrating for one proton and a disturbed dou-
blet at N 4.587 ascribed to resonance for the glycosidic proton
of GlcNAc-2 (integrating for one proton). The presence of ¢ve
enlarged singlets points to the presence of ¢ve mannose units.
Fig. 2. FACE analysis of CBHI N-glycans synthesized by T. reesei
VTT-D-80133 before and after transformation with the human
GlcNAc-TI gene. After enzymatic release of N-glycans from CBHI,
the complete mixture of N-glycans was £uorescently labelled with
ANTS and electrophoretically separated. The resulting glycan pat-
terns of transformed (lane 4) versus non-transformed T. reesei (lane
3) were compared. Upward shifts of N-glycans from the transform-
ant strain, corresponding to the addition of one sugar monomer,
were observed. One compound migrates to a position which is ex-
pected for GlcNAcMan5GlcNAc2 (arrow). An oligo-Glc standard
ladder served as reference (lane 1). G4 indicates the position of a
glucose tetramer. Man5ÿ9GlcNAc2 glycans from bovine ribonu-
clease B (lane 2) are additional references.
Fig. 3. (A) 1H-NMR spectrum at 500 MHz (without solvent suppression) of Man5GlcNAc2 (compound 1) in D2O solution. (B) Extension of
the region N 4.50^5.20.
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As usual for reducing oligosaccharides ending with GlcNAc-1
L(1-4) linked to GlcNAc-2, the spectrum is a superposition of
the two anomeric forms in a proportion of approximately 2/1
(L/K). The resonance at N 5.184, viz. integration 0.4 protons
and J(1,2) being 3.22 Hz, must be ascribed to the resonance
for H-1 of the K-form. The corresponding resonance for the
anomeric proton of the L-form is, as expected, hidden under
the HDO peak [15]. At N 2.034 and N 2.060, the two singlets
for the methyl resonances of the N-acetyl groups of the two
GlcNAc residues are found.
A L-Man residue Man-3 is (1-4)-linked to GlcNAc-2 and is
characterized by the chemical shifts of H-1 and H-2. The
chemical shift of H-2 of Man-3 at N 4.242 points to a disub-
stitution at C-3 and C-6 by K-Man-4 and K-Man-6. The res-
onance of H-1 is found at N 4.776 [19]. The chemical shifts of
the glycosidic protons of the residues Man-A and Man-B at
N 5.094 and N 4.904, respectively, show that they are terminal
[20]. For residue Man-4, the chemical shift of the resonance
for H-1 is 5.094, which also points to a terminal position, the
reference value being N 5.108 [21]. These data support the
structure of Man5GlcNAc2 (Fig. 3). The chemical shifts pre-
viously found for GlcMan7GlcNAc2 agree with the experi-
mental data obtained for this structure. For NMR, we assume
that the substitution is L(1,2), the L-D connection being veri-
¢ed by the value of 8.5 Hz of the vicinal coupling constant
J(1,2) of residue 5.
3.7. 1H-NMR data of compound 2 identi¢ed as
GlcNAcMan5GlcNAc2
The spectrum obtained with presaturation of the HDO
peak was studied (Fig. 4). Eight resonances, each integrating
for one proton, can be distinguished. There are ¢ve enlarged
singlets, pointing to the fact that this compound contains ¢ve
mannose residues. There is a doublet at N 5.183 with
J(1,2) = 2.5 Hz, integrating for 0.4 protons and ascribed to
the N-form of the reducing GlcNAc-1. At N 4.59, there is a
disturbed doublet integrating for one proton, assigned to H-1
of the reducing GlcNAc-2. Finally, at N 4.558, there is a dou-
blet, integrating for one proton with a coupling constant
J(1,2) = 8.5 Hz, pointing to a L-form of the third GlcNAc
residue. The presence of a supplementary GlcNAc is con-
¢rmed by inspection of methyl resonances of the NAc groups
in the region N 2.00^2.10, where three singlets, each integrat-
Fig. 4. (A) 1H-NMR spectrum at 500 MHz (without solvent suppression) of GlcNAcMan5GlcNAc2 (compound 2) in D2O solution. (B) Exten-
sion of the regions N 4.50^5.20 (resonance of the glycosidic and anomeric protons) and N 3.80^4.30 (resonance of the H-2 protons of mannose
residues).
Fig. 5. 1H-NMR chemical shifts of compounds 1 and 2 compared
with reference compounds: GlcMan7GlcNAc2 (compound 3 [15]), a
biantennary non-sialylated complex (compound 4 [19]), a non-sialyl-
ated hybrid (compound 5 [19]) and a sialylated hybrid (compound 6
[19]).
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ing for three protons, are found. As the compound is hydro-
lyzed from the peptide chain, GlcNAc-1 must show mutaro-
tation, so that the spectrum must be a superposition of the
two structures. At N 5.183, with an integration of 0.4 protons,
the resonance of the anomeric proton of the K-form is found.
That of the L-form is expected to occur at the same frequency
of the HDO peak.
Compounds 1 and 2 were compared with four other com-
pounds (Fig. 5). The chemical shifts of the glycosidic protons
of the residues Man-3, Man-4P, Man-A and Man-B of com-
pounds 2, 3 and 6 are very close to the corresponding values
in the basic compound 1, suggesting that this part of the
molecule remained unsubstituted. The value of the chemical
shifts of the residues A and B (N 5.085 for residue A and
N 4.900 for residue B) are typical when they are terminal
[20]. For non-terminal residues, a value of N 5.39^5.40 would
be expected for residue A, i.e. more than 0.30 ppm at a higher
frequency, and N 5.14 for residue B, i.e. 0.24 ppm at a higher
frequency. Hence, the substitution did not occur on either of
both compounds. The values of the chemical shifts of H-1 and
H-2 of residue Man-4 are typical in the case of substitution.
This is shown by the chemical shifts of these resonances in
compounds 4, 5 and 6. The resonance of H-1 of residue Man-
4 of compounds 4, 5 and 6 shows a down¢eld shift of this
proton for the corresponding non-substituted residue in com-
pound 1. When only a GlcNAc residue is L(1,2)-substituted
on Man-4, instead of N-acetyl-lactosamine (compounds 4 and
5) or even an elongated chain by a sialyl residue (compound
6), the down¢eld shift versus the non-substituted compound 1
is only 0.015 ppm. Although no reference values are available,
this small down¢eld shift points to a substitution [20] of res-
idue Man-4.
Sometimes, inspection of the resonances of H-2 is more
conclusive [21]. When residue Man-4 is not substituted (com-
pound 1), a chemical shift of N 4.067 is found for H-2. In the
case of L(1,2) substitution by GlcNAc (compounds 2, 4, 5 and
6), a down¢eld shift of 0.125^0.135 ppm is observed. Taking
into account the increment values previously proposed [20],
the present down¢eld shift for H-2 of Man-4 is diagnostic for
substitution. The resonance for H-1 of GlcNAc is found at
0.020 ppm if the unit is not further substituted by a galactose-
6 residue (compound 2), a frequency lower than when this
residue is further substituted. When the spectral data of com-
pound 2 are used as reference, we conclude that the supple-
mentary resonance at N 4.558, together with a coupling con-
stant J(1,2) of 8.5 Hz and the presence of a third methyl
resonance of a NAc group, suggests the presence of a supple-
mentary GlcNAc. Since the chemical shifts of the glycosidic
protons of the residues Man-A and Man-B allow us to con-
clude that these units are terminal, the third GlcNAc can only
be linked to Man-4. The chemical shifts of H-1 and H-2 of
Man-4 are in agreement with a L(1-2)-linked GlcNAc to Man-
4 (a conserved linkage).
4. Discussion
Mammalian glycosyltransferases were introduced in various
yeasts and ¢lamentous fungi and their expression and in vivo
transferring activity have been studied [7,22^24]. So far, suc-
cessful in vivo synthesis of a mammalian type N-glycan by a
fungus has not been demonstrated. The ¢rst enzyme needed to
be expressed in order to obtain a rudimentary hybrid N-gly-
can is GlcNAc-TI. The gene of rabbit GlcNAc-TI was intro-
duced in the genome of A. nidulans, which led to expression
and resulted in a fully active enzyme [7]. However, it was not
possible to demonstrate actual transfer of GlcNAc residues to
fungal oligosaccharides. An explanation for the inability to
demonstrate in vivo transfer of GlcNAc to fungal N-glycans
might be the choice of the host strain. Chen et al. [25] studied
N-glycans on invertase secreted by A. nidulans and suggested
the presence of galactomannans. In addition, it has been
shown that there are important strain-dependent di¡erences
in oligosaccharide structures [6,26]. While the acceptor sub-
strate Man5GlcNAc2 may be present in some strains [27^29],
it may not be synthesized in others. Hence, it is assumed that
the choice of a suitable fungal strain will be important to
allow successful and abundant in vivo synthesis of mamma-
lian-like N-glycans. Our results suggest that donor and accept-
or substrates are present in su⁄cient concentrations in the
secretion apparatus of T. reesei to allow in vivo synthesis of
hybrid N-glycans.
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